Died in Health Policy, companion bill(s) passed, see CS/HB 697 (Ch. 2026-4)
Summary
The bill would have the state set reference prices for prescription drugs based on cheaper foreign markets and forbid pharmacies from charging cash‑pay customers more than those prices. It also would force drug manufacturers to report international pricing data and limit how insurers and pharmacy benefit managers reimburse and change drug formularies. The aim is to lower out‑of‑pocket costs for patients while directing any savings to specific uses.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when SB 1158 changes status, plus AI-powered summaries and stage predictions.
Sign up free